M&A Deal Summary

Puracap Pharmaceutical Acquires Blu Caribe

On March 23, 2016, Puracap Pharmaceutical acquired life science company Blu Caribe

Acquisition Highlights
  • This is Puracap Pharmaceutical’s 2nd transaction in the Life Science sector.
  • This is Puracap Pharmaceutical’s 1st transaction in Puerto Rico.

M&A Deal Summary

Date 2016-03-23
Target Blu Caribe
Sector Life Science
Buyer(s) Puracap Pharmaceutical
Deal Type Add-on Acquisition

Target

Blu Caribe

Dorado, Puerto Rico
Blu Caribe, Inc. is a manufacturer and distributor of quality generic pharmaceuticals products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Puracap Pharmaceutical

South Plainfield, New Jersey, United States

Category Company
Sector Life Science
DESCRIPTION

Puracap Pharmaceutical LLC is a pharmaceutical company, that provides product development, manufacturing and distribution bringing, quality products & services.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Puerto Rico M&A 1 of 1
Year: 2016 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-23 Blu Pharmaceuticals

Franklin, Kentucky, United States

Blu Pharmaceuticals LLC is a manufacturer and distributor of pharmaceutical products.

Buy -